Pharma News

Deadly acute myeloid leukemia may be controlled by nutritious avocados

  • Posted on: 20 June 2015
  • By: Shalini.Sharma

Acute myeloid leukemia is a type of cancer of the blood and bone marrow that affects immature blood cell growth.It is fatal within five years for 90% of seniors over 65 years of age. Adding University of Waterloo scientists have found that the nutritious fruit may hold the key to beating deadly leukemia. They have discovered a lipid in avocados that combats AML by targeting the root of the disease - leukemia stem cells. The research is published in the Cancer Research.

WorldStar 2015 Award win by ACG Pharmapack’s anti-fog film

  • Posted on: 19 June 2015
  • By: Shalini.Sharma

ACG Pharmapack – a member of ACG Worldwide – is proud to have received the prestigious WorldStar 2015 Award from World Packaging Organization for its innovative. ACG Pharmapack, a member of ACG Worldwide, has received the prestigious WorldStar 2015 Award from World Packaging Organization for its innovative product, NoMist. An anti-fog packaging film, NoMist bagged the Award in the pharma & medical category, after having won the IndiaStar (organized by the Indian Institute of Packaging) and AsiaStar (organized by the Asian Packaging Federation) awards. The award ceremony and cocktail reception was held in Milan, Italy.

Waters launch Acquity Arc System: As a bridge between HPLC and UPLC methods

  • Posted on: 19 June 2015
  • By: Shalini.Sharma

Waters has introduced the Acquity Arc System, a quaternary liquid chromatograph that gives analytical laboratories running established LC methods a clear choice for replicating or improving their separations performance. The company intends to begin shipping the Acquity Arc system to customers by this month end.

Carna Biosciences & Janssen collaborates to develop small molecule protein kinase inhibitor

  • Posted on: 19 June 2015
  • By: Shalini.Sharma

Carna Biosciences, a leading provider of drug discovery supporting products and services, collaborate with Janssen Biotech, Inc. (Janssen), one of the Janssen Pharmaceutical companies of Johnson & Johnson, to develop and commercialize small molecule protein kinase inhibitor programmes.

A Long And Healthy Life by Eating 10 Grams of Nuts or Peanuts Per Day: Study Says

  • Posted on: 19 June 2015
  • By: Shalini.Sharma

A Study says, Peanuts can enhance your lifespan and lower mortality rates, but finds no protective effect for peanut butter.  The effects are equal in men and women. Nut consumption was assessed by asking about portion size and frequency of intake of peanuts, other nuts (tree nuts) and peanut butter. Men and women who eat at least 10 grams of nuts or peanuts per day have a lower risk of dying from several major causes of death than people who do not consume nuts or peanuts, the study said. The study was published in the International Journal of Epidemiology.

Scientist identify Gene Mutation Linked To Aggressive Form Of Brain Cancer ‘Anaplastic Oligodendroglioma’

  • Posted on: 18 June 2015
  • By: Shalini.Sharma

Scientists identified a gene by whose mutation is linked to the development of an aggressive form of brain cancer. An error in a gene called TCF12 is associated with more aggressive forms of a disease called anaplastic oligodendroglioma. The TCF 12 is the genetic code for a protein that binds to DNA and controls the activity of other genes. The study published in the journal Nature Communications.

US FDA approves Novartis' Promacta to treat chronic immune thrombocytopenia in childrens

  • Posted on: 18 June 2015
  • By: Shalini.Sharma

The US Food and Drug Administration (FDA) has approved Novartis' Promacta (eltrombopag) for the treatment of children six years and older with chronic immune thrombocytopenia (ITP) who have had an insufficient response to corticosteroids, immunoglobulins or splenectomy. Promacta was approved by the FDA in 2008 for use in adult patients with the same condition.

Jubilant Life Sciences raise price of Niacinamide by 10%

  • Posted on: 18 June 2015
  • By: Shalini.Sharma

Jubilant Life Sciences, one of the leading players in nutrition market and the largest manufacturers of vitamin B3 (Niacin and Niacinamide) in the world, announced a price increase of 10 per cent for Niacinamide, with immediate effect, for non-contract customers and wherever existing contracts permit. Niacin and niacinamide are forms of vitamin B3 and used in various pharmaceutical products.

Pan-India e-Pharmacy NetMeds.com first time launched in India

  • Posted on: 18 June 2015
  • By: Shalini.Sharma

The Dadha Group launched NetMeds.com. Netmeds is the “first-to-market” offering a consolidated, Pan-Indian solution for the quick online purchase and ensured fast delivery of prescriptions medications.  India’s first e-marketplace for pharma in the form of a portal  which offers an impressive selection of both prescription drugs and non-prescription products (OTC) drugs, supplying over 25,000 stock keeping units (SKUs) across India from its first warehousing hub in Chennai.  Prescription medication users will have opportunity to select their required medications from more than 260 drug categories for the chronic conditions, such as diabetes, hypertension and cholesterol control.

USFDA upgraded Jubilant’s Spokane facility from OAI to VAI status

  • Posted on: 18 June 2015
  • By: Shalini.Sharma

Jubilant Life Sciences Limited is an integrated global pharmaceutical and life sciences company engaged in manufacture and supply of APIs, generics, specialty pharmaceuticals and life science ingredients. It also provides services in contract manufacturing and drug discovery.  US Food and Drug Administration (USFDA) upgraded Jubilant Hollisterstier's pharmaceutical sterile manufacturing facility in Spokane, Washington (USA)  to the status of Voluntary Action Indicated (VAI). This upgradation by the USFDA from Official Action Indicated (OAI) to VAI is indicative of the cGMP status at the facility since receiving the warning letter in 2013.

Pages